2 results
Approved WMORecruiting
To assess the feasibility and efficacy of 90Y-ibritumomab tiuxetan consolidation treatment after R-PECC chemotherapy as second or third line treatment in patients with refractory or relapsed aggressive B-cell NHL, after or not eligible for…
Approved WMORecruiting
A randomized comparative study of the treatment of the insufficient greater saphenous vein: crossectomy with short strip vs Ultrasound guided foam sclerosis vs endovasculair laser. The Magna trial. The emphasis of this study will be on comparing the…